Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/1651
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Silva, H.J.en_US
dc.contributor.authorHerath, C.A.en_US
dc.contributor.authorSheriff, M.H.en_US
dc.date.accessioned2014-10-29T09:22:46Z
dc.date.available2014-10-29T09:22:46Z
dc.date.issued2005en_US
dc.identifier.citationLiver International. 2005; 25(5): 1074-5en_US
dc.identifier.issn1478-3223 (Print)en_US
dc.identifier.issn1478-3231 (Electronic)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/1651
dc.descriptionIndexed in MEDLINE
dc.description.abstractNo Abstract Available
dc.publisherWiley-Blackwellen_US
dc.subjectHepatitis B
dc.subjectHepatitis B-drug therapy
dc.subjectHepatitis B-virology
dc.subjectHepatitis B Surface Antigens
dc.subjectDNA, Viral
dc.subjectKidney Transplantation-adverse effects
dc.subjectLamivudine-therapeutic use
dc.subjectAntiviral Agents-therapeutic use
dc.titleLamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-upen_US
dc.typeLetter to Editoren_US
dc.identifier.departmentMedicineen_US
dc.creator.corporateauthorInternational Association for the Study of the Liveren_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.